V5E-31801-20006 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-24
Dose 1 — Pfizer-BioNTech
2021-10-15
Registered in v-safe
2021-10-15
Dose 2 — Pfizer-BioNTech
2021-10-15
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-10-16
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-10-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches

Adult check-in
2021-10-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-10-19
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-10-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-10-21
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Nausea, Diarrhea

Adult check-in
2021-10-22
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Fatigue or tiredness, Diarrhea

Adult check-in
2021-10-29
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-11-05
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-11-12
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-11-19
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-11-26
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-01-14
Survey response — 3 months, dose 2
MedDRA: Cough, Myalgia — Feeling: Fair

Free text: Cough muscle aches

MedDRA releases: 2024-11 · check-in free text available
2022-10-15
Survey response — 12 months, dose 2
MedDRA: COVID-19, Cough, Headache, Malaise, Pain, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Covid mid Sept fever cough aching, headache congestion generall malaise

MedDRA releases: 2024-11 · check-in free text available
2022-10-15
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-10-17
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-24	Pfizer-BioNTech	No
2	2021-10-15	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-10-15	Unsuccessful

Free text

Release 10 — 3 months, dose 2

2022-01-14

Symptoms: Cough muscle aches

Release 12 — 12 months, dose 2

2022-10-15

Symptoms: Covid mid Sept fever cough aching, headache congestion generall malaise

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Headache	·	·	✓
SD	Malaise	·	·	✓
SD	Myalgia	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release